Second Death in Trial of Experimental Alzheimer Drug Raising Concerns
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental drug for Alzheimer disease, calling into question the medication’s safety.A 65-year-old woman with early-stage Alzheimer d…
Learn MoreSecond Death in Trial of Experimental Alzheimer’s Drug Is Raising Concerns
TUESDAY, Nov. 29, 2022 (HealthDay News) — Two people have now died from brain hemorrhages that may be linked to an experimental Alzheimer’s drug, calling into question the medication’s safety.A 65-year-old woman with early-stage Alzheimer’s recently …
Learn MoreMost Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
MONDAY, Nov. 21, 2022 (HealthDay News) — Most pivotal trials of new cancer, cardiovascular, and neurologic drugs recruit from low- and middle-income countries (LMIC), according to a study published online Nov. 22 in the Annals of Internal Medicine.Fa…
Learn MoreEn medio de un aumento en los casos de VSR, hay esperanzas de una nueva vacuna
LUNES, 7 de noviembre de 2022 (HealthDay News) — Los bebés y los niños enfermos con el VSR están inundando los consultorios y los hospitales pediátricos de todo Estados Unidos, debido a un aumento temprano en el virus común de la infancia este año.Pe…
Learn MoreMany U.S. Adults Unlikely to Enroll in Drug Trials for Dementia Prevention
TUESDAY, Nov. 8, 2022 (HealthDay News) — Just over one in 10 adults aged 50 to 64 say they are very likely to participate in a dementia drug prevention trial, according to a study published online Oct. 19 in the Journal of Prevention of Alzheimer’s D…
Learn MoreLos ensayos clínicos podrían ayudar a frenar el Alzheimer. ¿Pero quién se apunta?
VIERNES, 4 de noviembre de 2022 (HealthDay News) — Unos nuevos medicamentos que pudieran ralentizar o prevenir el inicio de la demencia serían grandes avances, pero una nueva encuesta sugiere que muchos adultos de mediana edad podrían mostrarse renue…
Learn MoreAmid a Surge in RSV Cases, Hopes for a New Vaccine
MONDAY, Nov. 7, 2022 (HealthDay News) — Infants and children sick with RSV are flooding pediatricians’ offices and children’s hospitals across the United States, due to an early surge of the common childhood virus this year.But within one or two “sic…
Learn MoreClinical Trials Could Help Stop Alzheimer’s. But Who Will Join Them?
FRIDAY, Nov. 4, 2022 (HealthDay News) — New drugs that could slow or prevent the start of dementia would be groundbreaking, but a new poll suggests many middle-aged adults may be reluctant to take part in the studies that test those medications.Only …
Learn MorePain Relief in a FLASH: Radiation Treatments Lasting Seconds May Advance Cancer Care
WEDNESDAY, Oct. 26, 2022 (HealthDay News) — Flash radiotherapy, a new technology that uses targeted proton beams, is safe and effective in relieving pain for terminal cancer patients, a new, small study suggests. Flash radiotherapy delivers radiation…
Learn MoreNIH Investigating COVID-19 Experiments Conducted at Boston University
WEDNESDAY, Oct. 19, 2022 (HealthDay News) — The U.S. National Institutes of Health is investigating COVID-19 experiments at Boston University that have sparked a media firestorm, with some news outlets alleging that scientists created a “killer” stra…
Learn More